According to a report in The Business Standard, Novartis India has announced an agreement with Lupin to sell the Onbrez indacaterol inhalation capsules for the treatment of COPD in India. The newspaper cited “an industry source” for the information.
The article says that the capsules would be available in two doses, 150 mg and 300 mg. Few other details were reported.
Read the Business Standard article.
